Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Log in to access
Last updated: April 10, 2026Bookmark

Overview

Angina refers to chest pain on exertion. The chest pain is always sub-sternal, and is described as crushing/heavy, lasts minutes to hours, and may radiate to the upper arm or shoulder. 99% of cases are due to coronary artery disease. However, this transient period of ischemia is insufficient to cause necrosis. Episodes last less than 3 minutes and may be relieved with rest. Episodes > 30 minutes suggest unstable angina.

It is common in middle-aged and elderly men. Post-menopausal women are commonly affected. 10-20% of individuals with angina develop myocardial infarction or unstable angina within 1 year of diagnosis of stable angina

TermDefinition
Stable anginaChest pain on exertion that is relieved with rest
Unstable anginaChest pain on exertion that is NOT relieved with rest, or Chest pain that is new or worse than previous episodes
Prinzmetal’s anginaCyclical chest pain that may occur during rest. Due to vasospasm
Decubitus anginaChest pain precipitated by lying flat
Classification of angina
  • Risk factors for angina
  • Causes of angina
  • Pathophysiology
    1. Fixed atheromas cause vaso-occlusion → reduced coronary artery blood flow → increased oxygen demand during exertion → Subendocardial ischemia
    2. Hypertension → Concentric hypertrophy of the left ventricle → increased oxygen demand and hypoxia
    3. Thrombosis after rupture of atheromatous plaque → increased release of Thromboxane A2 from platelets and endothelin from endothelial cells → Vasoconstriction → ischemia
  • Signs and symptoms
    • Chest pain
      • Substernal
      • Lasting 30 seconds to about 30 minutes
      • Induced by exercise/sexual intercourse/climbing stairs/eating a heavy meal/emotional stress/cold temperature
      • Relieved by resting or nitroglycerin
      • Associated with breathlessness, sweating, nausea, or numbness and pain radiating to the upper arm or shoulder
  • Investigations
    • Electrocardiogram
      • ST-segment depression = subendocardial ischemia
      • Flat or inverted T-waves
    • Lipid panel
      • If LDL >100 or 70 in a diabetic, start the patient on a statin.
    • Complete blood count: usually within normal limits
    • Fasting blood glucose and HbA1C for Diabetes or pre-diabetes
    • Consider Chest X-ray and Echocardiogram
    • Angiography
      • Vasospasm of coronary arteries = Prinzmetal angina
    • Ergonovine challenge
      • Exacerbates pain in Prinzmetal angina
    • Functional imaging
      • Exercise echocardiography
      • Myocardial perfusion scintigraphy or cardiac MRI

Exercise Stress Test

A stress test is used to determine the severity of the disease in patients who have been diagnosed with angina. The results are used to determine whether the patient will need invasive treatment (after angiography).

A chemical stress test is preferred over an exercise stress test in patients whose exercise stress test is not possible or who have a pre-existing arrhythmia.

Stress testDescription
Exercise stress testThe patient is monitored on an EKG until they reach 80% of maximum heart rate (220 – age in years)
Chemical stress testDobutamine echo stress test and Dipyridamole-Thallium scintigraphy
  • Positive exercise stress test
    • Ischemia = ST depression ≥ 2mm
    • Hypotension = drop in systolic bP ≥ 10 mmHg
  • Positive Dobutamine echo stress test
    • Decreased cardiac wall movement
  • Positive Thallium scintigraphy
    • Decreased uptake of Thallium (thallium is identical to potassium and is taken up by myocytes)

Angiography

All patients with a positive stress test require an angiogram to determine the extent and severity of atherosclerosis. Patients subsequently require angioplasty with stenting (Percutaneous intervention – PCI) or Coronary artery bypass graft (CABG)

  • Indications for PCI in stable angina
    • Single vessel disease
  • Indications for CABG in stable angina
    • 3-vessel disease
    • Left main artery disease

Treatment of Stable Angina

The goal of treatment of angina is to reduce the risk of cardiovascular events (myocardial infarction, stroke, and death) and to improve quality of life by reducing symptoms of angina

  • Anti-anginal medications
    • Beta-blocker (metoprolol, atenolol, bisoprolol): first-line
    • Calcium channel blocker (amlodipine, diltiazem): a first-line alternative to beta-blockers
    • Long-acting nitrate (Isosorbide mononitrate): second-line
      • Side-effects → headache and postural hypotension
    • Ivabradine (funny Na inhibitor that reduces HR with minimal effect on BP): second line
      • Used in patients who cannot take beta-blockers
      • The patient must be in sinus rhythm before starting
    • Ranolazine (inhibits late Na+ current): second-line
      • Use with caution if there is heart failure, elderly, or weight <60kg or elderly
    • Nicorandil (activates K+ channels): second line
  • Symptom relief in angina
    • Nitroglycerin PRN
      • Side effects → headache, postural hypotension
      • Repeat dose of pain does not go away in 5 minutes
      • Call an ambulance if the pain does not go away within 5 minutes after the second dose
  • Secondary prevention in patients with angina
    • Daily Low-dose aspirin or clopidogrel (has a mortality benefit 😃)
    • Statin (atorvastatin) if LDL > 100mg/dL.
      • Target < 70mg/dL if diabetic
      • Target < 100mg/dL if non-diabetic
    • ACEi (captopril, lisinopril) if Diabetic
    • Lifestyle modification: Diet and exercise, weight loss, smoking cessation
  • Indications for statin
    • Coronary artery disease
    • Peripheral artery disease
    • Aortic disease
    • Carotid disease
    • Cerebrovascular disease
    • Diabetes + LDL > 100mg/dL.
    • Atherosclerotic Cardiovascular Disease 10-year risk > 7.5%
  • Definitive treatment of angina
    • Revascularization
      • Percutaneous intervention (PCI)
      • Coronary artery bypass graft (CABG)
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team